Patents
Literature
9 results about "Dopamine agonist" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A dopamine receptor agonist (DA) is a compound that activates dopamine receptors. There are two families of dopamine receptors, D₂-like and D₁-like, and they are all G protein-coupled receptors. D₁- and D₅-receptors belong to the D₁-like family and the D₂-like family includes D₂, D₃ and D₄ receptors. The DA are used in Parkinson’s disease and, to a lesser extent, to treat depression, hyperprolactinemia and restless leg syndrome.
Compositions and methods for treating neurological conditions
Compositions and methods for treating neurological conditions are provided. The present invention provides a pharmaceutical composition comprising a dopamine reuptake inhibitor or dopamine agonist, an adrenergic receptor antagonist, and a pharmaceutically acceptable carrier, and a method for treating a neurological disorder by administering the composition.
Owner:DRI BIOSCIENCES CORP
Device and method for providing a treatment recommendation based on a prediction of at least one impusle control disorder occurrence for a patient undergoing a treatment with dopamine agonists
PCT designated stageWO2026068209A1Medical data miningHealth-index calculationControl disordersImpulse control disorder
The present invention relates to methods and devices for providing a treatment recommendation based on a prediction of at least one Impulse Control Disorder occurrence for a patient undergoing a treatment with Dopamine Agonists.
Owner:INST DU CERVEAU & DE LA MOELLE EPINIERE ICM +4
Compositions and methods for treating erectile dysfunction and male hypogonadism
The invention provides a novel pharmaceutical composition comprising a phosphodiesterase type 5 (PDE5) inhibitor other than sildenafil and a dopamine agonist and method of use thereof for treating erectile dysfunction and / or male hypogonadism.
Owner:KONGS PHARMACEUTICAL CO
Use of nicotinic acetylcholine receptor alpha 7 activators
The present invention relates to the use of nicotinic acetylcholine receptor alpha 7 activators, in particular to the use of nicotinic acetylcholine receptor alpha 7 agonists for the treatment, prevention or delay of progression of dyskinesia associated with dopamine agonist therapy in Parkinson's disease.
Owner:NOVARTIS AG